Procurement Summary
Country: Czech Republic
Summary: Dns Lp 2026-014 - Natalizumab 2026
Deadline: 05 Jun 2026
Posting Date: 26 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 142064193
Document Ref. No.: SZ KZAS/037699/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: CZK 38732000
CPV Classification
33652100 - Antineoplastic agents
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
The subject of the public contract is the provision of continuous supplies of medicinal products with the active substance NATALIZUMAB for the needs of the contracting authority, as a provider of health services (not for the needs of resale/dispensing), including their direct shipment to pharmacies individual spin-off plants of the contracting authority, on the basis of a framework agreement concluded with one selected supplier for a period of 24 months from the conclusion of the framework agreement. Antineoplastics
DBID: 5124 System number: P26V00000177 File number: SZ KZAS/037699/2026 According to the law: No. 134/2016 Coll. Registration number in VVZ: Z2026-012056 Dynamic purchasing system: A dynamic purchasing system for the supply of medicinal products Start date: 25/05/2026 Offer submit by: 05/06/2026 10:00 Estimated value: 38, 732, 000 CZK without VAT
Documents
Tender Notice
2bf3cb941cd8588eb1e57bae5943add8.vyzva.k.podani.nabidky.dns.lp.natalizumab.2026.pdf
f3973967a3552bc22fd0c3b3760b59a6.01.specifikace.a.podklad.pro.zpracovani.cenove.nabidky.natalizumab.2026.xlsx
580136d6e9155bd04fca40f1c82e6fb3.02.ramcova.smlouva.natalizumab.2026.docx